Effects of lactic acid bacteria on cardiac apoptosis are mediated by activation of the phosphatidylinositol-3 kinase/AKT survival-signalling pathway in rats fed a high-fat diet

International Journal of Molecular Medicine

Volumn 35, Issue 2, 2015, Pages 460-470

  Wang, Hsueh Fang ^a   Lin, Pei Pei ^b   Chen, Chun Hua ^a   Yeh, Yu Lan ^c,d   Huang, Chun Chih ^e   Huang, Chih Yang ^b,f   Tsai, Cheng Chih ^a  

^a HUNGKUANG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^e Syngen Biotech Co   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Insulin like growth factor I receptor survival pathway; Obesity; Probiotic

Indexed keywords

CASPASE 9; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLINOSITOL 3 KINASE; PROBIOTIC AGENT; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; TRIACYLGLYCEROL; FAT INTAKE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY FAT; BODY WEIGHT; CELL SURVIVAL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; EPIDIDYMIS FAT; FLUID INTAKE; FOOD INTAKE; HEART LEFT VENTRICLE; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE CELL; HEART PROTECTION; HEART WEIGHT; LACTIC ACID BACTERIUM; LIPID DIET; MALE; NONHUMAN; OBESITY; RAT; SIGNAL TRANSDUCTION; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; DIET SUPPLEMENTATION; DRUG EFFECTS; EATING; FAT INTAKE; METABOLISM; PATHOLOGY; PHARMACOLOGY; WISTAR RAT;

ANIMALS; APOPTOSIS; DIETARY FATS; DIETARY SUPPLEMENTS; EATING; MALE; MYOCARDIUM; OBESITY; PHOSPHATIDYLINOSITOL 3-KINASES; PROBIOTICS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84919681567     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.2021     Document Type: Article

References (44)

1. Jang H, Conklin DJ and Kong M: Piecewise nonlinear mixed-effects models for modeling cardiac function and assessing treatment effects. Comput Methods Programs Biomed 110: 240-252, 2013.
2. Subramanian S, Turner MS, Ding Y, Goodspeed L, Wang S, Buckner JH, O'Brien K, Getz GS, Reardon CA and Chait A: Increased levels of invariant natural killer T lymphocytes worsens metabolic abnormalities and atherosclerosis in obese mice. J Lipid Res 54: 2831-2841, 2013.
3. Younce CW, Burmeister MA and Ayala JE: Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a. Am J Physiol Cell Physiol 304: C508-C518, 2013.
4. Sun W, Zhang Z, Chen Q, Yin X, Fu Y, Zheng Y, Cai L, Kim KS, Kim KH, Tan Y and Kim YH: Magnolia extract (BL153) protection of heart from lipid accumulation caused cardiac oxidative damage, inflammation, and cell death in high fat diet fed mice. Oxid Med Cell Longev 2014: 205849, 2014.
5. Hua Y, Zhang Y, Dolence J, Shi GP, Ren J and Nair S: CathepsinK knockout mitigates high fat diet-induced cardiac hypertrophy and contractile dysfunction. Diabetes 62: 498-509, 2013.
6. Li SY, Liu Y, Sigmon VK, McCort A and Ren J: High fat diet enhances visceral advanced glycation end products, nuclear O-Glc-Nac modification, p38 mitogen activated protein kinase activation and apoptosis. Diabetes Obes Metab 7: 448-454, 2005.
7. Barouch LA, Gao D, Chen L, Miller KL, Xu W, Phan AC, Kittleson MM, Minhas KM, Berkowitz DE, Wei C and Hare JM: Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res 98: 119-124, 2006.
8. Lee SD, Chu CH, Huang EJ, Lu MC, Liu JY, Liu CJ, Hsu HH, Lin JA, Kuo WW and Huang CY: Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. Am J Physiol Endocrinol Metab 291: E306-E314, 2006.
9. Haunstetter A and Izumo S: Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82: 1111-1129, 1998.
10. Narula J, Haider N, Arbustini E and Chandrashekhar Y: Mechanisms of disease: apoptosis in heart failure-seeing hope in death. Nat Clin Pract Cardiovasc Med 3: 681-688, 2006.
11. Fujio Y, Nguyen T, Wencker D, Kitsis RN and Walsh K: Akt promotes survival of cardiomyocytes invitro and protects against ischemia-reperfusion injury in mouse heart. Circ 101: 660-667, 2000.
12. Athanasiou A, Clarke AB, Turner AE, Kumaran NM, Vakilpour S, Smith PA, Bagiokou D, Bradshaw TD, Westwell AD, Fang L, Lobo DN, Constantinescu CS, Calabrese V, Loesch A, Alexander SP, Clothier RH, Kendall DA and Bates TE: Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun 364: 131-137, 2007.
13. Lee SD, Tzang BS, Kuo WW, Lin YM, Yang AL, Chen SH, Tsai FJ, Wu FL, Lu MC and Huang CY: Cardiac fas receptor-dependent apoptotic pathway in obese Zucker rats. Obesity 15: 2407-2415, 2007.
14. Lu MC, Tzang BS, Kuo WW, Wu FL, Chen YS, Tsai CH, Huang CY and Lee SD: More activated cardiac mitochondrial-dependent apoptotic pathway in obese Zucker rats. Obesity 15: 2634-2642, 2007.
15. Bishopric NH, Andreka P, Slepak T and Webster KA: Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol 1: 141-150, 2001.
16. Ren J, Samson WK and Sowers JR: Insulin-like growth factorI as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol 31: 2049-2061, 1999.
17. Vincent AM and Feldman EL: Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 12: 193-197, 2002.
18. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW and Liao JK: Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538-541, 2000.
19. Zhang Y, Yuan M, Bradley KM, Dong F, Anversa P and Ren J: Insulin-like growth factor 1 alleviates high fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function. Hypertension 59: 680-693, 2012.
20. Wang HT, Liu CF, Tsai TH, Chen YL, Chang HW, Tsai CY, Leu S, Zhen YY, Chai HT, Chung SY, Chua S, Yen CH and Yip HK: Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese mice. J Transl Med 10: 145, 2012.
21. Huang Y, Wang X, Wang J, Wu F, Sui Y, Yang L and Wang Z: Lactobacillus plantarum strains as potential probiotic cultures with cholesterol-lowering activity. J Dairy Sci 96: 2746-2753, 2013.
22. Park DY, Ahn YT, Park SH, Huh CS, Yoo SR, Yu R, Sung MK, McGregor RA and Choi MS: Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One 8: e59470, 2013.
23. Sanchez M, Darimont C, Drapeau V, Emady-Azar S, Lepage M, Rezzonico E, Ngom-Bru C, Berger B, Philippe L, Ammon-Zuffrey C, Leone P, Chevrier G, St-Amand E, Marette A, Dore J and Tremblay A: Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 111: 1507-1519, 2014.
24. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M and Astrup A: Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 54: 288-297, 2000.
25. Azzout-Marniche D, Chaumontet C, Nadkarni NA, Piedcoq J, Fromentin G, Tome D and Even PC: Food intake and energy expenditure are increased in high fat-sensitive but not in high carbohydrate-sensitive obesity prone rats. Am J Physiol Regul Integr Comp Physiol 2014.
26. Barbo-da-Silva S, Fraulob-Aquino JC, Lopes JR, Mandarim-de-Lacerda CA and Aguila MB: Weight cycling enhances adipose tissue inflammatory responses in male mice. PLoS One 7: e39837, 2012.
27. Park JE, Oh SH and Cha YS: Lactobacillus plantarum LG42 isolated from gajami sik-hae decreases body and fat pad weights in diet-induced obese mice. J Appl Microbiol 116: 145-156, 2014.
28. -/- mice. PLoS One 7: e46837, 2012.
29. Jung SP, Lee KM, Kang JH, Yun SI, Park HO, Moon Y and Kim JY: Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: A randomized, double-blind clinical trial. Korean J Fam Med 34: 80-89, 2013.
30. Tanida M, Imanishi K, Akashi H, Kurata Y, Chonan O, Naito E, Kunihiro S, Kawai M, Kato-Kataoka A and Shibamoto T: Injection of Lactobacillus casei strain Shirota affects autonomic nerve activities in a tissue-specific manner, and regulates glucose and lipid metabolism in rats. J Diabetes Investig 5: 153-161, 2014.
31. Fortuno MA, Ravassa S, Fortuno A, Zalba G and Diez J: Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management. Hypertension 38: 1406-1412, 2001.
32. McGowan BS, Ciccimaro EF, Chan TO and Feldman AM: The balance between proapoptotic and anti-apoptotic pathways in the failing myocardium. Cardiovasc Toxicol 3: 191-206, 2003.
33. Brown GC and Borutaite V: Nitric oxide, cytochrome c and mitochondria. Biochem Soc Symp 66: 17-25, 1999.
34. Torella D, Rota M, Nurzynska D, Musso E, Monsen A, Shiraishi I, Zias E, Walsh K, Rosenzweig A, Sussman MA, Urbanek K, Nadal-Ginard B, Kajstura J, Anversa P and Leri A: Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 94: 514-524, 2004.
35. Palmen M, Daemen MJ, Bronsaer R, Dassen WR, Zandbergen HR, Kockx M, Smits JF, van der Zee R and Doevendans PA: Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice. Circ Res 50: 516-524, 2001.
36. Wellen KE and Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119, 2005.
37. Heilbronn LK and Campbell LV: Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Design 14: 1225-1230, 2008.
38. Xu S, Zhi H, Hou X, Cohen RA and Jiang B: IκBβ attenuates angiotensin II-induced cardiovascular inflammation and fibrosis in mice. Hypertension 58: 310-316, 2011.
39. Li JJ and Chen JL: Inflammation may be a bridge connecting hypertension and atherosclerosis. Med Hypotheses 64: 925-929, 2005.
40. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE and Gewirtz AT: Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 328: 228-231, 2010.
41. Ebel B, Lemetais G, Beney L, Cachon R, Sokol H, Langella P and Gervais P: Impact of probiotics on risk factors for cardiovascular diseases. A review. Crit Rev Food Sci Nutr 54: 175-189, 2014.
42. Toral M, Gomez-Guzman M, Jimenez R, Romero M, Sanchez M, Utrilla MP, Garrido-Mesa N, Rodriguez-Cabezas ME, Olivares M, Galvez J and Duarte J: The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clin Sci (Lond) 127: 33-45, 2014.
43. Sobol KV, Belostotskaya GB and Nesterov VP: The effect of probiotics and their metabolic products on cardiovascular system cells in vitro. Dokl Biol Sci 436: 9-12, 2011.
44. Lin PP, Hsieh YM, Kuo WW, Lin YM, Yeh YL, Lin CC, Tsai FJ, Tsai CH, Huang CY and Tsai CC: Probiotic-fermented purple sweet potato yogurt activates compensatory IGF-IR/PI3K/Akt survival pathways and attenuates cardiac apoptosis in the hearts of spontaneously hypertensive rat. Int J Mol Med 32: 1319-1328, 2013.